🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/2010 | 6,06 | 6,14 | 5,91 | 5,95 | -3,05% | 3,70% | 140.583 |
| 10/11/2010 | 6,25 | 6,25 | 5,88 | 6,14 | -1,80% | 5,99% | 109.458 |
| 09/11/2010 | 6,29 | 6,29 | 6,18 | 6,25 | -0,59% | 1,79% | 82.474 |
| 08/11/2010 | 6,29 | 6,29 | 6,18 | 6,29 | +0,00% | 1,79% | 55.918 |
| 05/11/2010 | 6,29 | 6,33 | 6,21 | 6,29 | +0,00% | 1,79% | 138.553 |
| 04/11/2010 | 6,29 | 6,29 | 6,10 | 6,29 | +1,21% | 2,98% | 119.076 |
| 03/11/2010 | 6,29 | 6,29 | 6,06 | 6,21 | -1,19% | 3,57% | 61.235 |
| 02/11/2010 | 6,29 | 6,33 | 6,21 | 6,29 | +1,82% | 1,79% | 93.508 |
| 01/11/2010 | 6,10 | 6,21 | 6,06 | 6,18 | +1,85% | 2,45% | 70.425 |
| 29/10/2010 | 6,10 | 6,21 | 6,03 | 6,06 | -0,61% | 3,07% | 84.638 |
| 28/10/2010 | 6,14 | 6,14 | 5,95 | 6,10 | +0,00% | 3,05% | 61.502 |
| 27/10/2010 | 6,25 | 6,29 | 6,10 | 6,10 | -2,98% | 2,99% | 38.071 |
| 26/10/2010 | 6,21 | 6,29 | 6,14 | 6,29 | +0,60% | 2,41% | 37.751 |
| 25/10/2010 | 6,33 | 6,36 | 6,21 | 6,25 | -0,59% | 2,37% | 63.158 |
| 22/10/2010 | 6,18 | 6,33 | 6,10 | 6,29 | +2,44% | 3,64% | 66.257 |
| 21/10/2010 | 6,33 | 6,40 | 6,10 | 6,14 | -1,80% | 4,73% | 100.081 |
| 20/10/2010 | 6,14 | 6,33 | 6,06 | 6,25 | +1,83% | 4,27% | 31.018 |
| 19/10/2010 | 6,21 | 6,29 | 6,10 | 6,14 | -2,96% | 3,01% | 65.109 |
| 18/10/2010 | 6,21 | 6,40 | 6,10 | 6,33 | +2,42% | 4,82% | 152.899 |
| 15/10/2010 | 6,33 | 6,33 | 6,14 | 6,18 | -0,60% | 2,96% | 141.946 |
| 14/10/2010 | 6,25 | 6,33 | 6,21 | 6,21 | -0,60% | 1,80% | 160.941 |
| 13/10/2010 | 6,21 | 6,29 | 6,18 | 6,25 | +2,45% | 1,81% | 194.417 |
| 12/10/2010 | 5,95 | 6,10 | 5,95 | 6,10 | +1,88% | 2,52% | 43.949 |
| 11/10/2010 | 5,91 | 5,99 | 5,91 | 5,99 | +0,63% | 1,27% | 29.148 |
| 08/10/2010 | 5,99 | 5,99 | 5,80 | 5,95 | -0,63% | 3,13% | 94.978 |
| 07/10/2010 | 6,03 | 6,03 | 5,91 | 5,99 | +0,63% | 1,86% | 48.357 |
| 06/10/2010 | 5,95 | 6,03 | 5,80 | 5,95 | -0,63% | 3,77% | 58.643 |
| 05/10/2010 | 5,91 | 6,10 | 5,80 | 5,99 | +2,56% | 5,06% | 130.137 |
| 04/10/2010 | 5,88 | 5,91 | 5,76 | 5,84 | -1,26% | 2,55% | 50.521 |
| 01/10/2010 | 5,99 | 5,99 | 5,84 | 5,91 | +0,00% | 2,50% | 60.086 |